Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is focused on developing innovative small molecule drugs that target hematologic disorders, cancer and rare immune diseases. The Company announced positive topline results from a phase 2 evaluation of fostamatinib, an oral spleen tyrosine kinase (SYK) inhibitor, intended for the...
Vitiligo is an autoimmune condition that is characterized by loss of pigmentation, that affected 150, 000 Americans across all age groups according to a Burden of Skin Disease report commissioned by the American Academy of Dermatology in 2013. The total healthcare costs of Vitiligo were...
Alopecia Areata is an autoimmune / polygenic skin disease that causes loss of hair on the scalp and face and is estimated to affect over 6.8 million people in the U.S alone. There is currently no cure available for this disorder, with dermatologists using Corticosteroids, Minoxidil 5%, Anthralin and Diphencyprone (DPCP) as treatment options. However, these cause discomfort...
